Thomas G. Pretlow - Concepedia

Author

Thomas G. Pretlow

Also Known As

Alfred A. Bartolucci, Mary Ann O'Riordan, Michael C. McGinnis, Raju Kucherlapati, T G Pretiow, T G Pretlow, T PRETLOW, THOMAS G. PRETLOW, Theresa P. Pretlow, Thomas G Pretlow

110

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University University of Alabama at Birmingham University of Alabama National Cancer Institute University School

About

Thomas G. Pretlow is an author at Case Western Reserve University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	39	3.1K
2	Natural Sciences	5	5	277
3	Engineering	4	4	146
4	Health Sciences	1	1	30
5	Allergy	1	1	101

Thomas G. Pretlow

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
A new human prostate carcinoma cell line, 22Rv1 R. Michael Sramkoski, Thomas G. Pretlow, Joseph M. Giaconia, In Vitro Cellular & Developmental Biology - Animal UrologyGenitourinary CancerProstatic DiseaseMedicineTumor Biology	1999	588
Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells Jiann-an Tan, Yousuf Sharief, Katherine G. Hamil, Molecular Endocrinology Steroid MetabolismAndrogen ReceptorUrologyHormonal ReceptorAr Mrna	1997	358
Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate Theresa P. Pretlow, Mary Ann O’Riordan, Gregory A. Somich, Carcinogenesis Tumor BiologyF344 RatsChemoprevention StrategyOncogenic AgentTumor Incidence	1992	282
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Christopher W. Gregory, Katherine G. Hamil, Desok Kim, PubMed Androgen-deprived Recurrent Cwr22Increased ExpressionCancer BiologyTumor BiologyCwr22 Tumors	1998	273
Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Clifford G. Tepper, David L. Boucher, Philip Ryan, PubMed Tumor BiologyMedicineGeneticsHormonal ReceptorCwr22rv1 Cell Line	2002	264
Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer Liang Cheng, Thomas G. Pretlow, Fadi W. Abdul‐Karim, JNCI Journal of the National Cancer Institute	1998	208
Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade Hongzhen Li, Tommi J. Ahonen, Kalle Alanen, Cancer Research	2004	177
ErbB kinases and NDF signaling in human prostate cancer cells Adam W. Grasso, Duanzhi Wen, C. Miller, Oncogene MedicineReceptor Tyrosine KinaseErbb KinasesTumor SuppressorProstatic Disease	1997	144
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling Spyro Mousses, Urs Wagner, Yidong Chen, Oncogene UrologyAndrogen Responsive GenesHormonal ReceptorTumor SuppressorProstatic Disease	2001	126
P53 Oncogene Mutations in Human Prostate Cancer Specimens James Voeller, LA Vencia Y. Sugars, Thomas G. Pretlow, The Journal of Urology	1994	122

Page 1